Pediatric Risk Stratification Is Improved by Integrating Both Patient Comorbidities and Intrinsic Surgical Risk

Viviane G Nasr1, Steven J Staffa, David Zurakowski

  • 1From the Division of Cardiac Anesthesia (V.G.N., J.A.D.) Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts (S.J.S., D.Z.) the Division of Cardiac Anesthesia, Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario Canada (D.F).

Anesthesiology
|April 5, 2019
PubMed

Insights

This study developed a new pediatric surgical risk model incorporating procedure risk and patient comorbidities to predict 30-day mortality. The model accurately stratifies risk, improving patient care discussions and resource allocation.

Area of Science:

  • Pediatric surgery
  • Surgical outcomes research
  • Risk stratification

Background:

  • Current pediatric perioperative mortality risk models focus on patient comorbidities.
  • These models often overlook the intrinsic risk associated with specific surgical procedures.

Purpose of the Study:

  • To develop and validate a risk stratification model for pediatric perioperative mortality.
  • The model incorporates both patient comorbidities and the intrinsic risk of surgical procedures.

Main Methods:

  • Retrospective analysis of the American College of Surgeons National Surgical Quality Improvement Program Pediatric database.
  • Multivariable logistic regression used to identify predictors of 30-day mortality.
  • Internal and external validation of the developed risk model.

Main Results:

  • Analysis of 367,065 pediatric surgical cases revealed a 30-day mortality rate of 0.34%.
  • Intrinsic surgical risk, categorized by Current Procedural Terminology risk quartiles, significantly predicted mortality (P < 0.001).
  • The validated model demonstrated excellent discrimination (c-index = 0.95) for predicting 30-day mortality.

Conclusions:

  • Accurate perioperative risk estimation requires considering both patient comorbidities and surgical procedure risk.
  • This enhanced risk model can facilitate better patient-family-provider discussions.
  • The model may aid in cost analysis and resource allocation in pediatric surgery.
Abstract

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Design Example: Analyzing Capacity Contours for Flood Risk Assessment01:17

Design Example: Analyzing Capacity Contours for Flood Risk Assessment

Flood risk assessment involves careful planning and analysis to ensure the safety of communities near water retention structures. Capacity contours are a vital tool in this process, as they illustrate the potential spread of water at specific levels in a given area. In the context of building a bund across a small valley, these contours play a critical role in evaluating the safety of nearby residential areas.In this example, the bund is intended to store stormwater in the valley. The engineers...
293